2242792-25-0

2242792-25-0 structure

Name: AChE-IN-15
Chemical Name: AChE-IN-15
CAS Number: 2242792-25-0
Molecular Formula: C₂₃H₂₄N₂O₇
Molecular Weight: 440.45
Catalog: Signaling Pathways Neuronal Signaling AChE
Create Date: 2022-08-11 15:21:04
Modify Date: 2025-08-27 18:27:41
AChE-IN-15 (Compound 3d) is a reversible human acetylcholinesterase (huAChE) (IC50=6.8 μM) and human butyrylcholinesterase (huBChE) (IC50=16.1 μM) inhibitor. AChE-IN-15 shows significant antioxidant potency, AChE-IN-15 can be used for the research of Alzheimer’s disease[1].

Name	AChE-IN-15

Description	AChE-IN-15 (Compound 3d) is a reversible human acetylcholinesterase (huAChE) (IC50=6.8 μM) and human butyrylcholinesterase (huBChE) (IC50=16.1 μM) inhibitor. AChE-IN-15 shows significant antioxidant potency, AChE-IN-15 can be used for the research of Alzheimer’s disease[1].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> Neuronal Signaling >> AChE
In Vitro	AChE-IN-15 (compound 3d) inhibits huAChE and huBChE with IC50 values of 6.8 and 16.1 μM and inhibits RatAChE and RatBChE with IC50 values of 4.7 and 12.1μM[1]. AChE-IN-15 (compound 3d) (25 μM) inhibits self-mediated aggregation (77.9), huAChE-induced Aβ1-42 aggregation (73.6%), inhibit (78.9%) and disaggregate (64.6%) Cu2+-mediated Cu2+-mediated aggregation[1]. AChE-IN-15 (compound 3d) (25 μM) is an neuroprotective agent and displays hepatoprotective activity[1]. AChE-IN-15 (compound 3d) (25 μM) shows good blood-brain barrier (BBB) penetration[1]. AChE-IN-15 (compound 3d) (5-10 μM) displays neuroprotective effect on Aβ1-42-induced SH-SY5Y neurotoxicity[1]. Cell Cytotoxicity Assay[1] Cell Line: PC12 cells Concentration: 5 and 10 μM Incubation Time: 24 hours Result: Increased the cell viability to 63.9% (5 μM) and 72.3% (10 μM), respectively.
In Vivo	AChE-IN-15 (compound 3d) (5-20 mg/kg; 14 days; Kunming mice) can reverse cognitive deficit. Animal Model: Kunming mice[1] Dosage: 5, 10 and 20 mg/kg Administration: for 14 days Result: Reversed cognitive deficit induced by scopolamine.
References	[1]. Zhipei Sang, et al. Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease. Eur J Med Chem. 2020 Feb 1;187:111958.

Molecular Formula	C₂₃H₂₄N₂O₇
Molecular Weight	440.45

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2242792-25-0	2413656-04-7
2764664-52-8	2428389-65-3
2390042-05-2	177028-90-9
460345-17-9	2713548-95-7
2699090-78-1	2742707-36-2
2137777-96-7	2228769-33-1
2228150-89-6	2866333-85-7
2138243-02-2	2138394-43-9
2138394-47-3	2138516-56-8
2138509-61-0	2138170-09-7